Maxpro Capital Acquisition said its sponsor, MP One Investment, deposited $1,035,000 (10 cents a share) into the company’s trust for a deadline extension until Jan. 13. This is the first of two three-month extensions permitted under the SPAC’s governing documents and provides additional time for it to complete its merger with Apollomics.
Announced last month, terms call for for the biopharmaceutical company to receive up to $105 million of cash from the SPAC’s trust. The minimum cash condition is $20 million. Read more.
